UW Medicine researchers seek participants for Phase 3 clinical trial of a drug to treat monkeypox
UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.
Stay updated with breaking news from Human Monkeypox Virus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UW Medicine researchers are recruiting participants for a Phase 3 clinical trial of a drug to treat the monkeypox virus.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which expanded its focus to conduct research into COVID-19, today announced the initiation of STOMP (Study of Tecovirimat for Human Monkeypox Virus), or A5418, a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat for the treatment of human monkeypox.
ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the "Company") is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner
09.08.2022 - ALPHARETTA, GA / ACCESSWIRE / August 9, 2022 / RushNet, Inc (OTC PINK:RSHN), (the 'Company') is pleased to announce that heliosDX has launched its testing for the Human Monkeypox Virus through its partner laboratory effective today.With rising ...
Brazilian health authorities Friday confirmed the first death linked to monkeypox in the country: a 41-year-old man, who was already under treatment for other diseases, including cancer, which caused the worsening of his health condition.